Petra Financial Advisors Inc Pfizer Inc Transaction History

Petra Financial Advisors Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 01, 2023	BUY	$32.09 - $37.51 $29,201 - $34,134	910 Added 7.08%	13,772 $457 Million
Q2 2023 Jul 26, 2023	SELL	$36.12 - $41.79 $39,406 - $45,592	-1,091 Reduced 7.82%	12,862 $472 Million
Q1 2023 Apr 20, 2023	BUY	$39.39 - $51.28 $44,116 - $57,433	1,120 Added 8.73%	13,953 $569 Million
Q4 2022 Apr 10, 2023	BUY	$41.75 - $54.5 $535,777 - $699,398	12,833 New	12,833 $658 Million

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $149B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Petra Financial Advisors Inc, based on Form 13F filings with the SEC.

Stay updated on Petra Financial Advisors Inc with notifications on news.